Andrew Lee

11.0k total citations · 1 hit paper
42 papers, 1.7k citations indexed

About

Andrew Lee is a scholar working on Genetics, Oncology and Cancer Research. According to data from OpenAlex, Andrew Lee has authored 42 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Genetics, 13 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Andrew Lee's work include BRCA gene mutations in cancer (19 papers), Genetic Associations and Epidemiology (9 papers) and Global Cancer Incidence and Screening (9 papers). Andrew Lee is often cited by papers focused on BRCA gene mutations in cancer (19 papers), Genetic Associations and Epidemiology (9 papers) and Global Cancer Incidence and Screening (9 papers). Andrew Lee collaborates with scholars based in United Kingdom, United States and Australia. Andrew Lee's co-authors include Antonis C. Antoniou, Douglas F. Easton, Paul D.P. Pharoah, Marc Tischkowitz, Alex Cunningham, Jacques Simard, Tim Carver, Chantal Babb de Villiers, Fiona M Walter and Simon Hartley and has published in prestigious journals such as Journal of Clinical Oncology, Environmental Science & Technology and PLoS ONE.

In The Last Decade

Andrew Lee

41 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors

2019 386 citations Andrew Lee, Alex Cunningham et al. Genetics in Medicine profile →

Peers

Andrew Lee

GENET

ONCOL

PFM

L. Phuong United States

Shelly Cummings United States

Jennifer T. Loud United States

Rita K. Schmutzler Germany

Kent Hoskins United States

Lovise Mæhle Norway

Teresa Wagner Austria

Nina Ditsch Germany

Lucy Side United Kingdom

Maira Caleffi Brazil

L. Phuong United States

Andrew Lee

572 ×0.6

GENET

502 ×0.9

ONCOL

331 ×0.9

360 ×1.1

154 ×0.7

PFM

Citations per year, relative to Andrew Lee Andrew Lee (= 1×) peers L. Phuong

Countries citing papers authored by Andrew Lee

Since Specialization

Citations

This map shows the geographic impact of Andrew Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Lee more than expected).

Fields of papers citing papers by Andrew Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Lee. The network helps show where Andrew Lee may publish in the future.

Co-authorship network of co-authors of Andrew Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Lee. A scholar is included among the top collaborators of Andrew Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Lee. Andrew Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Volpe, Lucrezia della, Andrew Lee, Amy Deik, et al.. (2025). Inhibiting ferroptosis enhances ex vivo expansion of human haematopoietic stem cells. Nature Cell Biology. 27(12). 2214–2224.

Balbuena, Lloyd, et al.. (2024). Clozapine, relapse, and adverse events: a 10-year electronic cohort study in Canada. The British Journal of Psychiatry. 225(6). 572–578. 2 indexed citations

Lee, Andrew, et al.. (2023). Comprehensive systematic review and pooled analysis of real‐world studies evaluating immunomodulator and biologic therapies for chronic pouchitis treatment. JGH Open. 7(12). 899–907. 1 indexed citations

Li, Shuai, Robert J. MacInnis, Andrew Lee, et al.. (2022). Segregation analysis of 17,425 population-based breast cancer families: Evidence for genetic susceptibility and risk prediction. The American Journal of Human Genetics. 109(10). 1777–1788. 8 indexed citations

Wolfson, Michael, Steven D. Gribble, Nora Pashayan, et al.. (2021). Potential of polygenic risk scores for improving population estimates of women’s breast cancer genetic risks. Genetics in Medicine. 23(11). 2114–2121. 13 indexed citations

Choudhury, Parichoy Pal, Mark N. Brook, Amber N. Hurson, et al.. (2021). Comparative validation of the BOADICEA and Tyrer-Cuzick breast cancer risk models incorporating classical risk factors and polygenic risk in a population-based prospective cohort of women of European ancestry. Breast Cancer Research. 23(1). 22–22. 47 indexed citations

Kaplan, Celia P., Leah Karliner, Andrew Lee, et al.. (2021). Acceptability of an mHealth breast cancer risk-reduction intervention promoting risk assessment, education, and discussion of risk in the primary care setting. mHealth. 7. 54–54. 4 indexed citations

Archer, Stephanie, Chantal Babb de Villiers, Fiona Scheibl, et al.. (2020). Evaluating clinician acceptability of the prototype CanRisk tool for predicting risk of breast and ovarian cancer: A multi-methods study. PLoS ONE. 15(3). e0229999–e0229999. 44 indexed citations

Rodríguez‐Girondo, Mar, Andrew Lee, Rikje Ruiter, et al.. (2020). Validation of the BOADICEA model and a 313-variant polygenic risk score for breast cancer risk prediction in a Dutch prospective cohort. Genetics in Medicine. 22(11). 1803–1811. 42 indexed citations

10.

Lee, Andrew, et al.. (2020). The Financial and Psychosocial Impact of Medicinal Cannabis. The Medicine Forum. 2 indexed citations

11.

Zhang, Yue, Andrew Lee, Andrew T. Lambe, et al.. (2018). Kinetically controlled glass transition measurement of organic aerosol thin films using broadband dielectric spectroscopy. Atmospheric measurement techniques. 11(6). 3479–3490. 13 indexed citations

12.

Nyberg, Tommy, Koveela Govindasami, Goska Leslie, et al.. (2018). Homeobox B13 G84E Mutation and Prostate Cancer Risk. European Urology. 75(5). 834–845. 30 indexed citations

13.

Lee, Andrew, Alex Cunningham, Marc Tischkowitz, et al.. (2016). Incorporating truncating variants in PALB2, CHEK2, and ATM into the BOADICEA breast cancer risk model. Genetics in Medicine. 18(12). 1190–1198. 58 indexed citations

14.

Cai, Yi, et al.. (2016). Using Whole Exome Sequencing to Identify Candidate Genes With Rare Variants In Nonsyndromic Cleft Lip and Palate. Genetic Epidemiology. 40(5). 432–441. 26 indexed citations

15.

Muyan, Mesut, Linda M. Callahan, Yanfang Huang, & Andrew Lee. (2012). The ligand-mediated nuclear mobility and interaction with estrogen-responsive elements of estrogen receptors are subtype specific. Journal of Molecular Endocrinology. 49(3). 249–266. 13 indexed citations

16.

Choi, Seungtaek & Andrew Lee. (2011). Efficacy and safety of gonadotropin-releasing hormone agonists used in the treatment of prostate cancer. Drug Healthcare and Patient Safety. 3. 107–107. 20 indexed citations

17.

LaCroix, Andrea Z., TJ Powles, C. Kent Osborne, et al.. (2010). Breast Cancer Incidence in the Randomized PEARL Trial of Lasofoxifene in Postmenopausal Osteoporotic Women. JNCI Journal of the National Cancer Institute. 102(22). 1706–1715. 104 indexed citations

18.

Sun, Ning, Andrew Lee, & Joseph C. Wu. (2009). Long term non-invasive imaging of embryonic stem cells using reporter genes. Nature Protocols. 4(8). 1192–1201. 81 indexed citations

19.

McClung, Michael R., Ethel S. Siris, Steve Cummings, et al.. (2006). Prevention of bone loss in postmenopausal women treated with lasofoxifene compared with raloxifene. Menopause The Journal of The North American Menopause Society. 13(3). 377–386. 77 indexed citations

20.

Pinder, Sarah E., et al.. (2001). Pathological validation and significance of micrometastasis in sentinel nodes in primary breast cancer. Breast Cancer Research. 3(2). 113–6. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact